TFX
Price
$119.93
Change
-$2.17 (-1.78%)
Updated
Jun 13 closing price
Capitalization
10.49B
40 days until earnings call
TNDM
Price
$20.76
Change
-$0.16 (-0.76%)
Updated
Jun 13 closing price
Capitalization
2.32B
47 days until earnings call
Interact to see
Advertisement

TFX vs TNDM

Header iconTFX vs TNDM Comparison
Open Charts TFX vs TNDMBanner chart's image
Teleflex
Price$119.93
Change-$2.17 (-1.78%)
Volume$368.99K
Capitalization10.49B
Tandem Diabetes Care
Price$20.76
Change-$0.16 (-0.76%)
Volume$1.12M
Capitalization2.32B
TFX vs TNDM Comparison Chart
Loading...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TFX vs. TNDM commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFX is a StrongBuy and TNDM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (TFX: $119.93 vs. TNDM: $20.76)
Brand notoriety: TFX and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TFX: 63% vs. TNDM: 72%
Market capitalization -- TFX: $10.49B vs. TNDM: $2.32B
TFX [@Medical Specialties] is valued at $10.49B. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TFX’s FA Score shows that 1 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • TFX’s FA Score: 1 green, 4 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, TFX is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TFX’s TA Score shows that 3 TA indicator(s) are bullish while TNDM’s TA Score has 4 bullish TA indicator(s).

  • TFX’s TA Score: 3 bullish, 5 bearish.
  • TNDM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TNDM is a better buy in the short-term than TFX.

Price Growth

TFX (@Medical Specialties) experienced а -2.34% price change this week, while TNDM (@Medical Specialties) price change was -0.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.80%. For the same industry, the average monthly price growth was +3.14%, and the average quarterly price growth was +0.31%.

Reported Earning Dates

TFX is expected to report earnings on Jul 24, 2025.

TNDM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-1.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TFX($10.5B) has a higher market cap than TNDM($2.32B). TNDM has higher P/E ratio than TFX: TNDM (666.67) vs TFX (29.48). TFX YTD gains are higher at: -32.268 vs. TNDM (-42.365). TFX has higher annual earnings (EBITDA): 761M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. TFX (223M). TNDM has less debt than TFX: TNDM (416M) vs TFX (1.93B). TFX has higher revenues than TNDM: TFX (2.97B) vs TNDM (748M).
TFXTNDMTFX / TNDM
Capitalization10.5B2.32B452%
EBITDA761M-196.97M-386%
Gain YTD-32.268-42.36576%
P/E Ratio29.48666.674%
Revenue2.97B748M398%
Total Cash223M468M48%
Total Debt1.93B416M463%
FUNDAMENTALS RATINGS
TFX vs TNDM: Fundamental Ratings
TFX
TNDM
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8595
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
3793
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (13) in the Medical Specialties industry is significantly better than the same rating for TNDM (99). This means that TFX’s stock grew significantly faster than TNDM’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TNDM (100). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.

TFX's SMR Rating (85) in the Medical Specialties industry is in the same range as TNDM (95). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.

TFX's Price Growth Rating (64) in the Medical Specialties industry is in the same range as TNDM (64). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.

TFX's P/E Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for TNDM (93). This means that TFX’s stock grew somewhat faster than TNDM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TFXTNDM
RSI
ODDS (%)
Bullish Trend 6 days ago
69%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
56%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICMVX13.04N/A
N/A
Intrepid Capital Institutional
MNOWX35.90N/A
N/A
Manning & Napier Overseas Series W
VLCAX140.66N/A
N/A
Vanguard Large Cap Index Admiral
SGRKX37.70N/A
N/A
Allspring Growth Admin
MDEGX14.73N/A
N/A
BlackRock Unconstrained Equity Inv A

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-1.78%
A - TFX
48%
Loosely correlated
-1.54%
RVTY - TFX
45%
Loosely correlated
-2.27%
TNDM - TFX
45%
Loosely correlated
-0.76%
WAT - TFX
45%
Loosely correlated
-2.08%
IQV - TFX
44%
Loosely correlated
-1.41%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
-0.76%
TFX - TNDM
45%
Loosely correlated
-1.78%
CLPT - TNDM
40%
Loosely correlated
-4.47%
SHC - TNDM
40%
Loosely correlated
-2.72%
AZTA - TNDM
38%
Loosely correlated
+0.62%
A - TNDM
36%
Loosely correlated
-1.54%
More